Digital Health Leader’s Innovation in Real-Time Sensor-Based AI Sets New Standards for Personalized Cardiometabolic Care
COLUMBIA, Md., March 19, 2025 — Welldoc®, a digital health leader revolutionizing cardiometabolic care, today announced the issuance of four new patents, marking its 54th patent grant. This milestone underscores Welldoc’s relentless commitment to innovation and leadership in leveraging artificial intelligence (AI) and advanced predictive capabilities based on real-time sensor data. The company’s digital health platform empowers individuals with personalized AI-driven digital coaching to enable self-management of cardiometabolic conditions, positive lifestyle changes and improved overall health and outcomes.
The new patents focus on Welldoc’s unique approach to combining dense, sensor-based data specifically collected from Continuous Glucose Monitors (CGM), with AI to predict future engagement levels, health metrics and improved outcomes. This includes the development of a “CGM-GPT” model using generative AI techniques to predict future glucose values.
“Securing 50+ patents is a testament to the hard work of our talented team in the U.S. and India and their dedication to driving AI innovation in digital health,” said Kevin McRaith, President and CEO of Welldoc. “We are proud to have built a strong foundation of intellectual property that enables us to deliver impactful cardiometabolic care solutions and drive continuous innovation in our product development. Protecting the underlying algorithms and functions that power the Welldoc platform is crucial to our ability to partner with healthcare industry leaders and create a more sophisticated, personalized experience for our users.”
Welldoc continues to expand its intellectual property portfolio, securing protections for a wide range of AI-driven and CGM-focused innovations. These include machine learning algorithms based on aggregated, complex health data—such as medications, symptoms and device data—and generative AI algorithms for curated content delivery along with first-in-class advanced capabilities in quantitative prediction, including weight and glucose levels.
“It is well-known that generative, transformer-based AI models—most commonly known as large language models—may not work well for complex mathematical applications. They were designed to predict a series of words rather than numerical values,” said Anand Iyer, PhD, MBA, Chief AI Officer of Welldoc. “We are creating our own specialized large sensor models, designed to tackle complex mathematical tasks, such as predicting future glucose levels, ultimately focused on advanced improvement to personalized health.”
Welldoc currently has patents granted and pending in the U.S. and globally, with plans to expand.
About Welldoc
Welldoc®, a digital health leader revolutionizing cardiometabolic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, enabling improved health and outcomes. Welldoc’s comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support. Welldoc is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. The company partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs.
Welldoc has achieved 11 510(k) clearances for diabetes functionality within its digital health platform, and an IP portfolio of 50+ patents for its advanced AI and first-in-class tech. With over 90 clinical publications, Welldoc has also built an extensive library of clinical research, including many publications focused on the value of combining CGM with AI-powered digital health solutions. Welldoc is an industry thought leader and has been showcased in prestigious conferences and publications, including South by Southwest, The Wall Street Journal and The Economist. The company has been named the “Best Overall Digital Health Company” by MedTech Breakthrough for the past two years and was selected as a winner of the 2024 Healthcare AI Impact Awards, Innovation Awards by Business Intelligence Group and Top 100 Healthcare Technology Companies by the Healthcare Technology Report.. For more information, visit www.welldoc.com. Follow us on LinkedIn and Twitter.
Contact
CTD Comms
Megan Prock McGrath
573-578-1184
megan@ctdcomms.com
